GlassScriptPhysician profile
Bryan P Schneider
NPI 1811953433
$7,210.83
in general payments reported to CMS, 2019-2025
7 companies · $2,608 in 2025
The $2,608 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.40 · 2020: $4,550 · 2021: $11.92 · 2025: $2,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,600 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $843 · Travel and Lodging: $110 · Food and Beverage: $54.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,600.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $842.70 |
| Travel and Lodging | $110.02 |
| Food and Beverage | $54.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $6,204.79 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $952.72 | 2025 | |
| Genzyme Corporation | $17.49 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.86 | 2019 | |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| Pfizer INC. | $11.05 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.